此外,使用现行的药物目录来降低心脏病风险还是一件没有把握的事情。除了降血压的药物之外,处方里大量出现的还有降低胆固醇的他汀类药物。药物试验统计数字表明,为了防止在其它方面十分健康的病人出现第一次心脏病发作,数十位病人可能都会被开据他汀类药物的处方,但是没人确切知道这药对谁真正有用,对谁没有作用。
'It would be great if we could make some more paradigm-shifting discoveries,' said Michael Lauer, director of cardiovascular sciences at the NHLBI, which is a part of the National Institutes of Health.
美国国家卫生研究院下属 NHLBI的心血管学科主任迈克尔・劳尔(Michael Lauer)说:“如果我们能够在转变思维模式方面做出更多发现的话,那就太好了。”
Finding new treatments isn't the only aim of the new project. 'You could use existing therapies smarter,' said Joseph Loscalzo, chairman of medicine at Brigham and Women's Hospital in Boston.
找到新的治疗方法并不是新研究项目的唯一目的。波士顿布里格姆妇科医院(Brigham and Women's Hospital)的医务委员会主席约瑟夫・洛斯卡尔佐(Joseph Loscalzo)说:“你可以更高明地使用现存的疗法。”
The American Heart Association launched the initiative and has committed $30 million to it over the next five years. The AHA sees the project as critical to its goal to achieve a 20% improvement in cardiovascular health in the U.S. while also reducing deaths from heart disease and stroke by 20% for the decade ending in 2020, said Nancy Brown, the nonprofit organization's chief executive.
【心脏病治疗的最新前沿消息】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15